Pharmacist Portal Dispense an ePrescription
There was some very good (if not unexpected) news from the US overnight: the FDA has approved Lorcaserin as a weight loss pill...
Vivus Inc, the pharmaceutical company responsible for Qnexa, has announced that the Food and Drug Administration’s (FDA) decision on their weight loss drug is pending and to be released on July 17th...
We have heard that the FDA has delayed its final verdict on Qnexa until July...
It was announced last week that the advisory panel to the Food and Drug Administration (FDA) has recommended approval to market Qnexa as the latest weight loss treatment for obese patients...
Vivus has completed its analysis of past data relating to Topiramate, one of the ingredients in its proprietary weight loss medication, Qnexa...